STING1 and neoplasm: However, patient benefits often remain limited since cGAS/STING signaling is silenced in many tumor entities or antagonized, e.g., by the human papillomavirus (HPV)-associated oncoprotein E7 in HPV16-positive oropharyngeal carcinomas [21,22,23,24].